AbbVie Inc. (ABBV)
NYSE: ABBV
· Real-Time Price · USD
205.42
0.74 (0.36%)
At close: Aug 15, 2025, 12:14 PM
AbbVie Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.42B | 13.34B | 15.1B | 14.46B | 14.46B | 12.31B | 14.3B | 13.93B | 13.87B | 12.22B | 15.12B | 14.81B | 14.58B | 13.54B | 14.89B | 14.34B | 13.96B | 13.01B |
Cost of Revenue | 2.4B | 4B | 4.4B | 4.21B | 4.2B | 4.09B | 5.7B | 6.49B | 4.24B | 3.99B | 4.17B | 5.02B | 4.17B | 4.05B | 4.32B | 4.39B | 4.52B | 4.21B |
Gross Profit | 13.02B | 9.34B | 10.71B | 10.25B | 10.26B | 8.22B | 8.6B | 7.44B | 9.63B | 8.24B | 10.95B | 9.79B | 10.41B | 9.49B | 10.57B | 9.95B | 9.44B | 8.8B |
Operating Income | 5.86B | 3.73B | -1.49B | 3.83B | 4B | 2.8B | 3.19B | 2.28B | 4.51B | 2.77B | 5.5B | 4.6B | 3.29B | 4.72B | 5.07B | 4.31B | 4.44B | 4.1B |
Interest Income | n/a | 73M | 92M | 129M | 220M | 207M | 186M | 157M | 98M | 99M | 90M | 63M | 24M | 9M | 9M | 11M | 9M | 10M |
Pretax Income | 1.55B | 1.66B | -2.27B | 2.08B | 2.15B | 1.75B | 1.21B | 1.95B | 2.61B | 475M | 2.96B | 4.4B | 1.18B | 4.93B | 4.27B | 3.69B | 1.16B | 3.87B |
Net Income | 944M | 1.29B | -22M | 1.56B | 1.37B | 1.37B | 822M | 1.78B | 2.02B | 239M | 2.47B | 3.95B | 924M | 4.49B | 4.04B | 3.18B | 766M | 3.55B |
Selling & General & Admin | 3.22B | 3.29B | 2.88B | 4.21B | 3.38B | 3.31B | 3.19B | 3.37B | 3.27B | 3.04B | 3.42B | 3.3B | 5.41B | 3.13B | 3.26B | 3.08B | 3.07B | 2.84B |
Research & Development | 2.1B | 2.07B | 6.77B | 2.13B | 1.95B | 1.94B | 2.21B | 1.72B | 1.73B | 2.29B | 2.03B | 1.61B | 1.88B | 1.64B | 2.23B | 2.06B | 1.9B | 1.85B |
Other Expenses | 1.84B | 248M | 2.54B | 82M | 937M | 164M | n/a | 66M | 111M | 140M | -1M | 229M | -172M | n/a | n/a | 500M | n/a | n/a |
Operating Expenses | 7.16B | 5.61B | 12.2B | 6.42B | 6.26B | 5.42B | 5.4B | 5.16B | 5.11B | 5.47B | 5.45B | 5.15B | 7.12B | 4.77B | 5.49B | 5.65B | 5B | 4.69B |
Interest Expense | 678M | 700M | 702M | 720M | 726M | 660M | 564M | 555M | 552M | 553M | 566M | 560M | 556M | 548M | 580M | 596M | 615M | 632M |
Selling & Marketing Expenses | n/a | n/a | 2.1B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2B | n/a | n/a | n/a | 2.1B | n/a | n/a | n/a |
Cost & Expenses | 9.56B | 9.61B | 16.59B | 10.63B | 10.46B | 9.51B | 11.11B | 11.65B | 9.35B | 9.46B | 9.62B | 10.21B | 11.29B | 8.82B | 9.81B | 10.04B | 9.52B | 8.91B |
Income Tax Expense | 613M | 372M | -2.25B | 520M | 773M | 383M | 388M | 172M | 583M | 234M | 493M | 448M | 255M | 436M | 226M | 508M | 394M | 312M |
Shares Outstanding (Basic) | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
Shares Outstanding (Diluted) | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.77B |
EPS (Basic) | 0.53 | 0.72 | -0.02 | 0.88 | 0.78 | 0.77 | 0.46 | 1.00 | 1.14 | 0.13 | 1.40 | 2.23 | 0.52 | 2.54 | 2.29 | 1.78 | 0.42 | 2.00 |
EPS (Diluted) | 0.53 | 0.72 | -0.02 | 0.88 | 0.78 | 0.77 | 0.46 | 1.00 | 1.14 | 0.13 | 1.39 | 2.22 | 0.51 | 2.53 | 2.26 | 1.78 | 0.42 | 1.99 |
EBITDA | 2.23B | 4.4B | 535M | 4.88B | 5B | 4.49B | 3.85B | 4.74B | 5.42B | 3.15B | 5.69B | 7.17B | 3.79B | 7.53B | 6.83B | 6.41B | 3.98B | 6.71B |
EBIT | 2.23B | 2.36B | -1.57B | 2.8B | 2.87B | 2.42B | 1.78B | 2.51B | 3.16B | 1.03B | 3.53B | 4.96B | 1.74B | 5.48B | 4.85B | 4.28B | 1.78B | 4.5B |
Depreciation & Amortization | n/a | 2.04B | 2.1B | 2.08B | 2.13B | 2.07B | 2.08B | 2.23B | 2.26B | 2.13B | 2.16B | 2.21B | 2.05B | 2.05B | 1.98B | 2.13B | 2.2B | 2.21B |